New path to treat advanced triple-negative breast cancer

A new study by researchers at Yale Cancer Center shows inhibition of the CECR2 gene prevents triple-negative breast cancer from advancing or

Related Keywords

Keisuke Aoshima ,Xuanlin Che ,Meiling Zhang ,Yao Li ,Jocelynf Chen ,Tianrui Xu ,Zongzhiz Liu ,Asako Aoshima ,Wesleyl Cai ,Qin Yan ,Hongyin Sun ,Davidl Rimm ,Saraj Rutter ,Veerle Bossuyt ,Axiang Chen ,Zhenwei Tang ,Yangyi Zhang ,Sabinem Lang ,Department Of Defense Breast Cancer Research Program ,Scientific Co ,National Institutes Of Health ,Yale Cancer Center ,Cancer Research Award ,Epigenetics Research Program ,Breast Cancer Of Yale Center ,Yale Cancer Center Class ,Science Translational ,Associate Professor ,Yale School ,Scientific Co Director ,Breast Cancer ,Yale Cancer ,Defense Breast Cancer Research Program ,National Institutes ,Research Award ,Lok Hei Chan ,Lajos Pusztai ,Mingzhu Yin ,Translational Medicine ,